Radiation-induced erectile dysfunction in patients with prostate cancer: current methods of radiotherapy-Reference-Cited by-同舟云学术

Radiation-induced erectile dysfunction in patients with prostate cancer: current methods of radiotherapy

Published:2020-11-19 Issue:3 Volume:16 Page:143-152
ISSN:1996-1812
Container-title:Cancer Urology
language:
Short-container-title:Onkourologiâ

Author:

Novikov R. V.¹^ORCID,Novikov S. N.²^ORCID,Protoshchak V. V.³,Dzhalilov I. B.⁴

Affiliation:

1. N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia; Saint-Petersburg State University

2. N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia

3. S.M. Kirov Military Medical Academy, Ministry of Defense of Russia

4. Saint-Petersburg State University

Abstract

In recent years, significant changes have taken place in the treatment of prostate cancer. Modern radiation treatment technologies are beginning to take a leading position not only in localized and locally-advanced forms of the disease, but also in the case of oligometastatic process. This encourages a natural interest in various aspects of radiation therapy of prostate cancer, in particular its effects on erectile function status. Analysis of domestic literature shows the complete absence of publications on the technical possibilities of radiation therapy to preserve potency after treatment. The purpose of this work was to highlight this critical issue.

Publisher

Publishing House ABV Press

Subject

Urology,Nephrology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference58 articles.

1. Hamdy F.C., Donovan J.L., Lane J.A. et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016;375(15):1415-24. DOI: 10.1056/NEJMoa1606220.

2. Jackson W.C., Silva J., Hartman H.E. et al. Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies. Int J Radiat Oncol Biol Phys 2019;104(4):778-9. DOI: 10.1016/j.ijrobp.2019.03.051.

3. Wang Z., Ni Y., Chen J. et al. The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis. World J Surg Oncol 2020;18(1):42. DOI: 10.1186/s12957-020-01824-9.

4. Mohler J.L., Antonarakis E.S., Armstrong A.J. Prostate cancer, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(5):479-505. DOI: 10.6004/jnccn.2019.0023.

5. Mahase S.S., D'Angelo D., Kang J. et al. Trends in the use of stereotactic body radiotherapy for treatment of prostate cancer in the United States. JAMA Netw Open 2020;3(2):e1920471. DOI: 10.1001/jamanetworkopen.2019.20471.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological aspects of implantation of a Russian prostate-rectum spacer based on stabilized hyaluronic acid of non-animal origin;Cancer Urology;2024-05-17

2. Technologies to reduce radiation toxicity in prostate cancer patients: spacers - a simple and effective solution;Cancer Urology;2021-11-11

3. PRIAPOS trial: new conception of pathogenesis of post-brahytherapy erectile dysfunction;Cancer Urology;2021-05-06